American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bone marrow surveillance of pediatric cancer survivors identifies clones that predict therapy-related leukemia
    Journal Article

    Spitzer, B.; Rutherford, K. D.; Gundem, G.; McGovern, E. M.; Millard, N. E.; Arango Ossa, J. E.; Cheung, I. Y.; Gao, T.; Levine, M. F.; Zhang, Y.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Integrated analysis of ovarian juvenile granulosa cell tumors reveals distinct epigenetic signatures and recurrent TERT rearrangements
    Journal Article

    Vougiouklakis, T.; Zhu, K.; Vasudevaraja, V.; Serrano, J.; Shen, G.; Linn, R. L.; Feng, X.; Chiang, S.; Barroeta, J. E.; Thomas, K. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Radioimmunotherapy targeting Delta-like ligand 3 in small cell lung cancer exhibits antitumor efficacy with low toxicity
    Journal Article

    Tully, K. M.; Tendler, S.; Carter, L. M.; Sharma, S. K.; Samuels, Z. V.; Mandleywala, K.; Korsen, J. A.; Reyes, A. M. D.; Piersigilli, A.; Travis, W. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Telaglenastat plus cabozantinib or everolimus for advanced or metastatic renal cell carcinoma: An open-label phase I trial
    Journal Article

    Meric-Bernsta, F.; Tannir, N. M.; Iliopoulos, O.; Lee, R. J.; Telli, M. L.; Fan, A. C.; DeMichele, A.; Haas, N. B.; Patel, M. R.; Harding, J. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase Ib/II randomized study of RO4929097, a gamma-secretase or notch inhibitor with or without vismodegib, a hedgehog inhibitor, in advanced sarcoma
    Journal Article

    Gounder, M. M.; Rosenbaum, E.; Wu, N.; Dickson, M. A.; Sheikh, T. N.; D'Angelo, S. P.; Chi, P.; Keohan, M. L.; Erinjeri, J. P.; Antonescu, C. R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Facts and hopes in prediction, diagnosis, and treatment of immune-related adverse events
    Review

    Smithy, J. W.; Faleck, D. M.; Postow, M. A.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors
    Journal Article

    Demetri, G. D.; De Braud, F.; Drilon, A.; Siena, S.; Patel, M. R.; Cho, B. C.; Liu, S. V.; Ahn, M. J.; Chiu, C. H.; Lin, J. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A urinary drug-disposing approach as an alternative to intravesical chemotherapy for treating nonmuscle invasive bladder cancer
    Journal Article

    Bellat, V.; Michel, A. O.; Thomas, C.; Stokol, T.; Choi, B. B.; Law, B.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Understanding drug sensitivity and tackling resistance in cancer
    Review

    Tyner, J. W.; Haderk, F.; Kumaraswamy, A.; Baughn, L. B.; Van Ness, B.; Liu, S.; Marathe, H.; Alumkal, J. J.; Bivona, T. G.; Chan, K. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • ImmunoPET of ovarian and pancreatic cancer with AR9.6, a novel MUC16-targeted therapeutic antibody
    Journal Article

    Sharma, S. K.; Mack, K. N.; Piersigilli, A.; Pourat, J.; Edwards, K. J.; Keinänen, O.; Jiao, M. S.; Zhao, H.; White, B.; Brooks, C. L.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: